Q-BOND
Live / Registered — Registered — Section 71 accepted (as of 13 May 2020)
What this means for you
Registered since 12 Jan 2010. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79057369
- Registration number
- 3737065
- Mark type
- Stylized text
- Filed
- 25 Mar 2008
- Published for opposition
- 27 Oct 2009
- Registered
- 12 Jan 2010
- Attorney of record
- Victoria Friedman
Goods and services
- Class 001 — Chemicals: chemical, biochemical and biotechnological preparations for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes; non-medical reagents and solvents for scientific and medical research use, namely, for [ sample preparation, and for marking, separating, isolating, purifying, ] amplifying and analyzing natural or synthetic biopolymers, in particular nucleic acids, oligonucleotides [ proteins, macromolecules and biologically active substances ]; kits comprising chemical preparations for scientific purposes, namely, for [ the preparation of samples, and for the marking, separating, isolating, purifying, ] amplifying and analysis of natural or synthetic biopolymers, in particular nucleic acids, oligonucleotides [ proteins, macromolecules and biologically active substances, in particular nucleic acids] of biological or biochemical samples material
- Class 005 — Pharmaceuticals: [ diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; diagnostic preparations for medical and veterinary purposes, in particular diagnostics, in particular for sample preparation and for marking, separating, isolating, purifying, amplifying and analysis of biopolymers, in particular nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological preparations, in particular reagents for medical use, namely, for sample preparation, and for the conduction of marking, separating, isolating, purifying, amplifying and analysis methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; in vitro diagnostic preparations for medical purposes, kits comprising diagnostic preparations for medical or veterinary-diagnostic purposes, in particular for sample preparation, and for marking, separating, isolating, purifying, amplifying and analysis of biopolymers, in particular nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material; all purpose disinfectants]
Owner
- QIAGEN GmbH, Hilden, DE
- QIAGEN GmbH, DE
- QIAGEN GmbH, DE
Prosecution history
- 15 Jan 2021 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 13 Jan 2021 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 13 May 2020 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 13 May 2020 — REGISTERED-SEC.71 ACCEPTED
- 29 Feb 2020 — POST REGISTRATION ACTION MAILED - SEC.71
- 07 Feb 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Jan 2020 — TEAS SECTION 71 RECEIVED
- 12 Jan 2019 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 18 Oct 2018 — NEW REPRESENTATIVE AT IB RECEIVED
- 26 Apr 2018 — INTERNATIONAL REGISTRATION RENEWED
- 23 Jun 2017 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 28 Apr 2017 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 28 Apr 2017 — INVALIDATION PROCESSED
- 30 Nov 2016 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 30 Mar 2016 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED